HOME > ARCHIVE
ARCHIVE
- Metabolic Syndrome Should Be Prevented by Reducing Visceral Fat: Dr Matsuzawa
May 9, 2005
- NEW PRODUCTS
May 9, 2005
- REGULATORY NEWS IN BRIEF
May 9, 2005
- JPMA's Pharmaceutical Affairs Committee to Make Proposals
May 9, 2005
- More Info. on Hepatitis C Should Be Shared with the Public: Korosho Council
May 9, 2005
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
April 25, 2005
- JMA Opposed to Medical License Renewal: Dr Uematsu
April 25, 2005
- Bayer Yakuhin Aims for Sales of \100 Bil. by 2010
April 25, 2005
- Working Group
April 25, 2005
- CROs Should Be General "Pharma Support Providers": Mr Nakamura
April 25, 2005
- The Reporter's Eye: 8
April 25, 2005
- Nichi-iko to Assign Expert MRs to DPC Hospitals
April 25, 2005
- JIRA Presents Data on Economic Benefits of Image Diagnosis
April 25, 2005
- Nichi-iko Aims to Be GE Drug Leader through New 3-Year Plan
April 25, 2005
- Consortium to Negotiate Better Fees for Image Diagnosis
April 25, 2005
- BULLETIN
April 25, 2005
- Japan's First Electronic Poster Display System Introduced
April 25, 2005
- Alfressa Announces New 3-Year Management Plan
April 25, 2005
- Kodak to Expand Its Solution Business
April 25, 2005
- Suzuken Announces Upward Revisions in FY2004 Business Forecast
April 25, 2005
ページ
In the complex landscape of the Japanese pharmaceutical market, the “status quo” is often the safest harbor. But for leaders like Kennet Brysting, former president of Gilead Japan, the status quo is the most dangerous place to stay.Innovation in Japan…
